- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fuji adds automatic monitoring to PACS
Fujifilm Medical Systems USA introduced a comprehensive set of automated remote monitoring services for its Synapse PACS at the Healthcare Information and Management Systems Society annual conference in Orlando, Feb. 22 to 26. Active Monitoring
Fujifilm Medical Systems USA introduced a comprehensive set of automated remote monitoring services for its Synapse PACS at the Healthcare Information and Management Systems Society annual conference in Orlando, Feb. 22 to 26. Active Monitoring continuously and securely monitors and logs performance metrics of a facility's Synapse system. The goal is to proactively detect system anomalies and remedy them before they cause serious problems. Performance metrics include CPU and memory utilization and available disk space. Specific component and status information, including operating system/application version and patch levels, and network address, are monitored and measured against predetermined performance thresholds. When it detects conditions that are out-of-tolerance, Active Monitoring automatically alerts an appointed system administrator, via e-mail or pager, to remedy the issue.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
